TriMaster: Randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea - A MASTERMIND study protocol

  • Catherine Angwin
  • , Caroline Jenkinson
  • , Angus Jones
  • , Christopher Jennison
  • , William Henley
  • , Andrew Farmer
  • , Naveed Sattar
  • , Rury R. Holman
  • , Ewan Pearson
  • , Beverley Shields (Lead / Corresponding author)
  • , Andrew Hattersley

Research output: Contribution to journal › Article › peer-review

15 Citations (Scopus)
137 Downloads (Pure)

Fingerprint

Dive into the research topics of 'TriMaster: Randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea - A MASTERMIND study protocol'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science